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activity of the whole secretome. Proteomic characterisation of the EV and free secretome fraction show the presence of numerous molecules specific to each fraction that could be key regulators of tissue regeneration. Intriguingly we show that the EVs only contain miRNA and not mRNA. This suggests tissue regeneration in the host is mediated by the action of EVs modifying existing, rather than the imposition of new, signalling pathways. The EVs harbour significant anti-inflammatory activity as well as promoting angiogenesis; the latter may be the mechanistic explanation for their ability to promote muscle regeneration after cardiotoxin injury. 
Abstract
The secretome of human amniotic fluid stem cells (AFSC) has great potential as a therapeutic agent in regenerative medicine. However it must be produced in a clinically compliant manner before it can be used in humans. Here we developed a means of producing a biologically active secretome from AFSCs that is free of all exogenous molecules. We demonstrate that the full secretome is capable of promoting stem cell proliferation, migration and protection of cells against senescence.
Furthermore, it has significant anti-inflammatory properties. Most importantly we show that it promotes tissue regeneration in a model of muscle damage. We then demonstrate that the secretome contains extracellular vesicles (EV) that harbour much but not all the biological activity of the whole secretome. Proteomic characterisation of the EV and free secretome fraction show the presence of numerous molecules specific to each fraction that could be key regulators of tissue regeneration. Intriguingly we show that the EVs only contain miRNA and not mRNA. This suggests tissue regeneration in the host is mediated by the action of EVs modifying existing, rather than the imposition of new, signalling pathways. The EVs harbour significant anti-inflammatory activity as well as promoting angiogenesis; the latter may be the mechanistic explanation for their ability to promote muscle regeneration after cardiotoxin injury. 
Introduction
Stem cells are able to undergo numerous asymmetric cell divisions giving rise to one daughter that reverts to its parental state and the other capable of differentiation [1] . In a classical scenario, the differentiated cell carries out repair of only the resident tissue. However an extensive body of research has shown that in many cases the differentiating cell is multipotent. These findings have been exploited to develop therapies in which one conveniently isolated stem cell population can be used to treat numerous damaged tissues [2, 3] . As such, it is assumed that stem cells make a direct cellular contribution to the regenerated tissue. However in many instances following the introduction of stem cells, robust tissue regeneration was evident but with minimal stem cell engraftment [4] [5] [6] . This had led to a paradigm shift in our understanding of stem cell mediated tissue repair through the proposition that stem cells secrete molecules which activate host cells that are the cellular mediators of regeneration [7] . The notion of a paracrine effect is supported by many studies which show that stem cells secrete a spectrum of proteins, small RNAs and mRNAs which have biological activity [8] [9] [10] . In this scenario, secreted stem cell factors modulate host cellular signalling pathways e.g. promoting an anti-inflammatory response or by protecting against senescence [4, 11, 12] . A number of studies have shown that factors released by stem cells are packaged in a variety of phospholipid membrane bound extracellular vesicles (EVs), including microvesicles and exosomes [10, 13] . Several species of EV, such as exosomes, are shed constitutively but more so during cellular stress [14] . Release of EVs from the cell is believed to enable effective long-range signal transduction by protecting the cargo against degradation. Furthermore it is proposed that molecules on the surface of EVs permit homing to specific tissues, thereby facilitating a degree of target specificity [15] .
Numerous studies have focused on identifying an optimal population for stem cell therapies by taking into account differentiation repertoire, ease of isolation, longevity and any associated ethical issues. One particularly attractive source is amniotic fluid derived stem cells (AFSCs). These cells support the regeneration of bone [2] , lung [16] , kidney [17, 18] , intestine [4] , heart [19] and skeletal muscle [20, 21] . They are easily isolated from human amniotic fluid which is routinely collected during clinical prenatal diagnostic procedures such as amniocentesis and which is not associated with any ethical issues. Furthermore human AFSCs have been shown capable of approximately 250 population doublings [22] . However in many reports, regeneration takes place without significant AFSC engraftment again pointing to a paracrine mechanism of action [4, 9] .
In this study we determined whether a human AFSC secretome collected under conditions concordant with clinical translation would support tissue regeneration. Specifically we wanted to 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   o  r  P  e  e  r  R  e  v  i  e  w  O  n  l  y  /  N  o  t  f  o  r  D  i  s  t  r  i  b  u  t  i  o  n   5 obviate contamination with non-human proteins/molecules including those found in foetal calf serum. We developed conditions which allowed the collection of a secretome which was not only serum free but induced cellular stress without promoting cell death. Here we report that the human AFSC secretome produced in nutrient free and hypoxic conditions contains a spectrum of proteins and miRNA. The whole secretome protected against senescence and promoted stem cell proliferation and migration. Using reporter cell lines we demonstrate significant anti-inflammatory potential of the human AFSC conditioned media (AF-CM). In vivo experiments show that the AF-CM promoted skeletal muscle regeneration. We then isolated and characterised the EV fraction (AF-EV)
from AF-CM and showed that it too had anti-inflammatory properties and protects against senescence. We profiled the protein and miRNA cargo of both the EV and non EV fraction and found that each contained specific entities. Importantly we show that AF-EVs were able to promote adult mouse muscle regeneration.
Methods
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Conditioned media (CM) generation and extracellular vesicle (EV) isolation At 10 passage, AFSCs
were pelleted at 300g in 1.5 mL microfuge tubes at a density of 1x10 6 cells/tube. Cells were incubated in 400μl sterile PBS for 24 hours. Following incubation the cells were pelleted at 300 g for 5 minutes, the supernatant was aspirated, pooled and centrifuged at 2,000 g for 20 minutes. The supernatant (AF-CM) was collected and stored at -20°C. AF-EVs were isolated using sequential 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 2 O before freezing and blocking in OCT. 10µm cryo-sections were taken using a Bright OT5000
cryostat. Cells and pellet sections were imaged using a bright field microscope. Subsequently, cells were then washed twice in PBS and incubated with 2.5mg/ml X-Gal solution for 18 hours at 37ᵒC in the dark [23] . Subsequently, wells were rinsed twice with PBS and then twice with methanol before air drying. Cells stained blue were considered senescent and assays visualised using a Zeiss A1 inverted Epi-fluorescent Microscope.
NF-κB p65 Nuclear Translocation Assay U251 cells were cultivated on cell-culture treated cover slips for 24 h. After 24 h pre-treatment with CM, cells were exposed to 10 ng/ml TNF-α for 30 minutes.
Cells were washed using PBS and fixed in 4% paraformaldehyde (4% PFA, 15 min, RT).
Permeabilisation and blocking was carried out as previously described [24] . NF-κB-p65 was detected and mounting in medium containing 2.5μg/ml DAPI. Imaging was carried out using Zeiss Axioimager
Epifluorescence microscope and p65 nuclear pixel intensity was measured using ImageJ software. with the lentiviral pGreenFireTM-NF-κB-GFP-Luciferase Reporter construct (System Biosciences) and functionality was confirmed after puromycin selection (5 µg/ml, Apollo scientific) and clonal growth (data not shown). After cells were treated with 2% CM for 24 h, medium was removed and cells were treated with 10 ng/ml TNF-α. Lysing of the cells was performed after 24 h using cell culture lysis buffer (Promega), and activity of luciferase was measured after applying firefly luciferase reporter assay system (Promega) according to manufacturer's guidelines using Lucy 1 luminometric plate reader (Anthos).
NF
In Vivo Cardiotoxin induced Mouse TA Injury and AFSC CM/EV Treatment C57BL/6 mice (12 week old) were tail vein injected with 100μL either hAFSC CM, hAFSC EV or ultra-centrifuged PBS. 30
Minutes later mice were injected with a total of 30μL 50μM Naja pallida cardiotoxin (CTX) (Latoxan, Valence France) into the tibialis anterior (TA). After 5 days mice were sacrificed and TA muscles were collected and immediately frozen.
Histology Frozen Tibialis Anterior (TA) muscles were embedded in Tissue-TEK® OCT compound (PST).
12μM cryo-sections were processed for immunohistochemistry [24] . 
Uptake of PKH26-stained EVs by IMR-90 cells AF-EV staining was carried out using the PKH26 Red
Fluorescent Cell Linker Kit (Sigma). IMR-90 cells cultured until 70% confluency and treated for 3 in water) within 120 min [25] . MaxQuant software version 1.4.1.2 was used to identify proteins based on peptides and to perform label-free quantification [26] . Both mass spectrometry and MaxQuant parameters were set as previously described [27] . The analysis of Molecular Function GO terms was performed trough Perseus software version 1.5.8.5 using Fisher's exact test with a p-value threshold of 0.02 [28] .
Sample preparation for Mass Spectrometry (MS) AF-EV and non-EV fraction isolated from
miRNA Array and analysis GeneChip® miRNA 4.0 Arrays were used to analyze the miRNA content of AF-EVs using FlashTag™ Biotin HSR RNA Labeling Kits according to the manufacturer´s instructions.
Probe cell intensity data (CEL) from Affymetrix GeneChip miRNA 4.0 Arrays were analyzed in the Affymetrix Expression Console™ software. Normalization was performed using the Robust Multichip Analysis (RMA) + DABG algorithm [29] . Only miRNAs calculated as present in all 3 samples were declared as generally expressed after 24 hours. Focus was given to the miRNAs present with the highest signal intensities (top 50). For these top 50 miRNAs validated target mRNAs were amalgamated using miRWalk2.0 software [30] . In the next step, GO Slim classification for biological process was performed using WebGestalt software to provide a high-level functional classification for validated target mRNAs [31] . Morpheus software was used to design the Heat-map showing intensity variability between biological replica (n=3) for the top 50. seconds and negative contrasted using 1% uranyl acetate. Grids were air dried and analysed using a Zeiss 906 transmission microscope (Zeiss, Germany).
Statistics All experiments were performed three times unless otherwise stated. Statistical analysis was performed using GraphPad Prism software. Data analysed between multiple groups was tested using one-way ANOVA followed by Tukey's post-hoc testing. For comparison between two groups, independent sample t-tests were completed. Significance values were always set at the 95% confidence interval. All p values were indicated as p < 0.05 (*), p < 0.01 (**) or p < 0.001 (***). All data are displayed as mean ± SEM.
Results
AFSCs retained multipotency following the collection of AF-CM rich in protein and nucleic acid (Figure 1)
AF-CM contained a high level of protein (834.25μg/ml ± 72.73) and a low level of nucleic acid 
AF-CM is able to suppress NF-κB signalling (Figure 2A-E)
The ability of AF-CM to modulate the inflammatory response was tested using U251 cells stimulated with TNF-α which resulted in an increase of nuclear NF-κB p65 ( Figure 2D ). Treatment with AF-CM for 24 hours before and during TNF-α stimulation led to a reduction in nuclear p65 by 42.5% from 2.28±0.02 to 1.31±0.11 ( Figure 2D ), at levels comparable to unstressed U251 control cells. Activity of NF-κB activity was quantitatively demonstrated using a NF-κB -Luciferase/GFP lentiviral infected Figure 2E ). TNF-α elevated the levels of NF-κB dependent luciferase by 46.3%, which was reduced by 15.4% to 40±1.63 with AF-CM. AF-CM treatment alone showed no change in NF-κB dependent luciferase activity compared to non-TNF-α stimulated control U251 cells. Therefore AF-CM attenuates NF-κB activity, a transcription factor widely regarded to regulate pro-inflammatory signalling [32] .
AF-CM modulates exogenous stem cell properties and protect against cellular stress (Figure 2F-G)
The efficacy of AF-CM as a regulator of cellular behaviour was assessed by examining three properties: (i) the ability to reduce levels of cellular senescence, (ii) promote proliferation and (iii)
migration. Firstly, we demonstrated a reduction in H 2 O 2 -induced senescence associated β-gal staining ( Figure 2F ) following AF-CM treatment stress exposure, from 88.75%±4.39 to 73.25%±1.89.
Additionally, AF-CM increased the proliferation capability of Adipose Derived Mesenchymal Stem Cells (ADMSCs) at a range of concentrations ( Figure 2G ). The 30% increase in cell number attributed to the lowest concentration of AF-CM was similar to changes seen with higher CM concentrations, but 2.5% AF-CM induced the optimal increase in ADMSC migration in a wound closure assay ( Figure   2H ). Therefore AF-CM demonstrates an ability to protect against senescence induced through stress as well as to promote the proliferation and migration of allogeneic stem cells.
AF-CM enhances regeneration in an in-vivo acute muscle injury model (Figure 3)
In order to directly assess its regenerative capabilities, AF-CM was intravenously injected into mice prior to injecting naja mossambica mossambica CTX intra-muscularly into the Tibilalis Anterior (TA). Figure 3I -J).
AF-CM extracellular vesicle size is characteristic of exosomes and they are rich in miRNA (Figure 4)
Step-wise ultracentrifugation was used to isolate the extracellular vesicles (AF-EV) from the AF-CM.
The RNA profile showed that the AF-EV fraction was almost exclusively made up of small species (~21-25 nucleotides in size ( Figure 4A) ). Small RNAs such as miRNA are known to be vulnerable to enzymatic breakdown and have been proposed as being contained within extracellular vesicles released by cells for inter-cell communication [33, 34] . Size analysis of vesicles was originally carried out to determine the type of vesicle being secreted by the AFSCs AF-CM ( Figure 4B-C) . Average vesicle diameter was 72.5±4.66 nm suggesting that the majority were exosomes. Levels of protein within the AF-EV were found to be very high (595 μg/ml). Vesicular proteins in the AF-EV were compared to those found in the whole AF-CM using silver staining ( Figure 4D ). Silver staining of proteins in the AF-EV revealed a higher concentration of proteins within the 40-50kDa range compared to the wide spectrum of proteins found in the AF-CM ( Figure 4D ). Fluorescent red PKH26
stained AF-EVs were taken up by IMR-90 target cells and staining was found situated within the cells as opposed to the cell membrane ( Figure 4E ).
AF-CM extracellular vesicles protect against cellular stress and suppress NF-κB activation (Figure 5)
In vitro assays testing cellular protection from senescence and ability to reduce NF-κB activity were carried out to compare the AF-EV fraction to the whole AF-CM. The p65 nuclear translocation assay ( Figure 5A-E) showed the AF-EV provided a 34.3% greater suppressive effect on the translocation compared to AF-CM (1.47±16.15 and 2.39±0.12 respectively). Quantitative evaluation of AF-EV NF-κB activity via the luciferase based assay showed no change in luciferase expression compared to the AF-CM, ( Figure 5F ). The AF-EV fraction induced a decrease in the levels of H 2 O 2 -induced senescence by 78% (from 35.50±1.99 to 7.58±0.94, Figure 5G ). However, there were no differences in senescence between the whole and AF-EV fractions.
AF-EV retain the ability to enhance regeneration within an acute muscle injury model in-vivo
(Figure 6)
Regeneration of CTX damaged TA muscle was used to determine whether the AF-EV fraction promoted muscle regeneration. CSA of newly regenerating TA fibres was increased by AF-EV treatment compared to the CTX damage control (926.66μm 2 ±24.23 and 484.51μm 2 ±68.27 respectively), resulting in a 91.2% increase in size of newly formed fibres ( Figure 6A-B) . Levels of Figure 6E-F) . AF-EV treatment did not alter the levels of quiescent ( Figure 6G ), activated satellite cells ( Figure 6H ) and committed progenitor cells ( Figure 6I ) compared to that of the CTX damage control. In vivo analysis of AF-EV regenerative capabilities showed that treated mice presented with increased vascularisation and regenerating fibres with a larger CSA following CTX damage compared to vehicle treated controls.
AF-EV harbour unique proteins and regeneration promoting miRNA (Figure 7-8)
Mass spectrometry was used to identify proteins in both the AF-EV and non-EV fraction from the human AFSCs secretome ( Figure 7B ). A total of 856 protein groups were identified. A variety of proteins were found present in both the soluble fraction and EV fraction of the AF-CM ( Figure 7A ).
However, a very distinctive quantitative protein profile was found in the EV fraction compared to the soluble fraction ( Figure 7B ). 416 protein species were shared between the two fractions. However 250 protein species were unique to the soluble fraction whereas 190 species were exclusive to the AF-EV fraction (Figure 7a ). Proteins enriched in the different AF-CM fractions were shown to be important in shared cellular processes (Table 1) , cellular processes individual to that of the soluble fraction (Table 2 ) and processes only found to be controlled by proteins within the AF-EV fraction (Table 3) . Of interest were the Heat-Shock family of proteins present in the AF-CM. A large number of Heat-Shock proteins were secreted, some of which were found only within the AF-EV fraction including HSPA (70kDa)-4L, whereas others were found only in the soluble fraction including the mitochondrial 60 kDa heat shock protein (HSPD-1). Finally many were found in both fractions e.g. ribonucleoprotein was also found in the AF-EV fraction, whilst no RISC complex associated proteins were found in either fraction.
Detailed analysis of the AF-EV miRNA led to the identification of 586 miRNA species and 21399 pathway targets ( Figure 8B ). The majority of miRNA were found to target mRNA controlling processes such as metabolic activity ( Figure 8B ) but also more specifically responses to stress ( Figure   8C ). Within the top 50 miRNAs in the AF-EV, many were postulated to promote angiogenesis, proliferation, migration, differentiation and autophagy such as miR382, miR24-3p and miR3960 [35] [36] [37] . Other species of miRNA found potentially inhibit apoptosis, including miR3196, miR762, miR125b-5p and miR1273-3p [38] [39] [40] [41] . Whilst others present such as miRNA let-7b-5p are known to also possess anti-inflammatory effects [42, 43] .
Discussion
Our extensive characterisation of AF-CM and its AF-EV fraction created under non-physiological conditions from human AFSCs provides crucial information about their protein and RNA cargo. We demonstrated that human AFSC derived AF-CM and AF-EV were able to modulate allogeneic stem cell activity and inflammatory signalling. Our results showed that alterations in inflammatory signalling following treatment with AF-CM were mediated at least in part through NF-κB pathway repression. Furthermore, our data suggests that many paracrine factors that support regeneration were in the AF-EV. Interestingly, the RNA fraction of the secretome was made entirely of miRNA and lacked mRNA molecules.
Much promise surrounds the clinical potential for MSCs in regenerative therapies. Foetal derived
MSCs, such as AFSCs may have greater differentiation potential compared to their adult counterpart, such as adipose derived MSCs [22] . AFSCs are multipotent and promote regeneration of an array of tissues [4, 9, 22] . However, the ability of AFSCs and other stem cells to regenerate tissue is often through the paracrine acting secretome which include proteins and RNA molecules [4, 8] . Paracrine factors are often found in membrane bound vesicles such as exosomes and microvesicles that aid transit for cell communication and protect the cargo from degradation [34] . Low levels of basal EV secretion are often increased after stress [14] . The ability to increase EV shedding following stress was proposed as a means to produce a more potent secretome [44] . Additionally, cell-free based therapies reduce the risk of immunological reactivity often associated with the use of whole cells.
The potential for tumorigenesis using whole cells is also avoided and it is believed that cell-free therapies are a safer option for clinical use.
Previous studies have either used whole stem cells or basal medium and/or serum derived CM collected under physiological conditions [4, 10] . Collection of AF-CM in PBS, at room temperature as used in this study was postulated to induce cellular stress which would enhance the secretion of regenerative molecules [44] . It concords with a recent study which demonstrated that hypoxia promoted EV secretion from human AFSCs [45] . However in our study, we used even more severe conditions and demonstrated that not only did the human AFSCs survive 24 hours in non-optimal A wealth of evidence shows that paracrine factors released by stem cells are packaged into small membrane bound EVs [10, 34, [46] [47] [48] . We isolated vesicles from our AF-CM which exhibited an average diameter of 72.5nM which is consistent with them being exosomes rather than microvesicles [34, 49] . Protein analysis also provided evidence for the presence of exosomes due to the existence of known structure specific markers such as CD63, HSP70, HSP90, ACTB, GAPDH and 14-3-3 protein zeta/delta (YWHAZ) [50, 51] . AF-EV cargo profiling identified a number of polypeptides unique to this fraction. Presence of specific proteins within the AF-EV fraction and soluble fraction implies that both may have therapeutic value and contrasts suggestions promoting the use of AF-EV fractions alone [45] . Our data shows that although the AF-EV may provide the AFCMs principle effects, the use of the AF-EV alone could lead to the loss of potentially important protein species for regeneration.
The library of excreted paracrine factors identified using mass spectrometry suggests that they alter the cellular signalling activity in target cells. Identification of Heat-shock proteins was of particular interest. For example the presence of Heat-shock protein 70 in the AF-CM which has been previously shown to initiate a preparatory like signalling mechanism in order to brace cells for incoming stress [52] [53] [54] . Furthermore, the 'alarmin' protein HMGB1 was present in the CM which may further potentiate the protective mechanisms [55] . A reduction in the level of H 2 O 2 -induced senescence following AF-CM treatment also showed a protective effect. The suggestion that there is a safe guarding against cellular stress following tissue necrosis could in part be explained by the presence of these alarmins within the AF-CM. In-vitro experiments showed that AF-CM increased proliferation and migration of ADMSCs, thus showing an ability to modulate allogeneic stem cell activity in favour of regeneration. AF-CM caused no aggravation of a pro-inflammatory response in itself.
Interestingly, a capacity to reduce NF-κB-p65 nuclear translocation and TNF-α driven NF-κB activity, demonstrated the ability of AF-CM to reduce inflammation, a key characteristic required for regeneration [56] .
Our work also sheds light into the possible role of AFSCs in their natural environment, the amniotic fluid. It has been shown that there is an increase in p65 signalling towards the end of a pregnancy which is believed to help trigger labour. It is conceivable that AFSCs play a role in dampening p65 signalling and therefore prevent pre-term labour but also constrain a pro-inflammatory environment known to be damaging for the foetus [57] [58] [59] . We suggest that this is a regulated process such that periods of stress promote the secretion of anti-inflammatory molecules by AFCs into the amniotic fluid.
Treating IMR-90 cells with PKH26 stained AF-EVs not only showed that AF-EVs were capable of being taken up by target cells but it also provided further evidence that uptake was via an active process.
The lack of stained membrane lipid around the periphery of the cell and instead presence within the cell suggests that the AF-EV membranes did not fuse with the target cell membrane. Instead its uptake has been proposed to be facilitated by active mechanisms such as endocytosis, preparing cargo endocytic compartment sorting [60, 61] . Membrane bound receptors and transporters are thought to aid the facilitation of EV fusion and uptake into target cells [34] . It has been previously hypothesised that EV adsorption is cell specific enabling cellular responses such as angiogenesis [34, 48] . Endothelial progenitor derived EVs targeting to endothelial cells is believed to be facilitated by surface alpha4 and beta1 integrins [48] . In contrast, our data shows a regenerative response for the AF-CM and AF-EV in a number of cell types. In keeping with this, mass spectrometry profiling failed to find any specific cell surface targeting protein. These data therefore provide evidence that the AF-CM protective effects are not specific to one cell type but afford cellular protection to a spectrum of cell types. Again this is hypothesised to be of benefit during pregnancy to protect the foetus. This suggests that AF-CM may be therapeutically amenable for use in a number of pathological situations and tissues.
The A2B1 ribonucleoprotein is known to transport miRNA into EVs. The presence of this protein in the AF-EV fraction supports the idea that loading of the miRNA in this compartment is a regulated process [62] . miRNA must be protected for long range transport and signalling due to their instability and susceptibility to enzymatic degradation. Protection can be facilitated via interaction with the RISC protein complex. However, mass spectrometry failed to detect RISC complex proteins. We suggest the role of providing miRNA stability is fulfilled by EVs. Packing of miRNA into EVs not only protects them from degradation but may be essential for their biological action. Indeed recent research has demonstrated that naked circulating miRNA has no biological activity. This property is imbued following their encasement in EV [13] . One very important finding of this study was that all the RNA in the CM was miRNA with no evidence of mRNA [33, 48, 63, 64] . This signifies that AF-CM modifies endogenous programmes of the existing target cells rather than imposing ones that are completely foreign. Enhanced regenerative properties of the EV fraction demonstrated here could be attributed to the presence of miR125b-5p, miR3196 and miR762, which target pro-apoptotic and senescence related mRNA [40] . Suppression of keap1 mRNA by miRNA125b-5p has been shown to inhibit both FAS induced apoptosis and APAP induced necrosis leading to the inhibition of acute liver failure [40] . In addition, targeting of the RNF4 gene by miR762 inhibits apoptosis by inducing DNA repair mechanisms [39] . The modulation of H2AX expression by miR3196 and downregulation of PUMA/p53/p21 signalling was shown to inhibit apoptosis but also suggests a subsequent suppression of downstream senescence [38] . Importantly some of the identified miRNAs, notably
Let-7b, have been previously shown to be anti-inflammatory [42] . A recent study by Balbi et al profiled miRNA in a AF-CM with regenerative properties [45] . However none of their candidates feature on the list of top 50 miRNA found in our samples. We suggest that the types of miRNA produced by human AFSCs depend on culture conditions and many miRNA regulate mRNA that control regeneration.
Suppression of NF-κB signalling by the AF-EV fraction was shown to be equal to, or stronger than that of the whole AF-CM. This implies that the components subduing NF-κB activity reside mainly in the EV fraction. Our data provides direct evidence of AF-CM and AF-EV having anti-inflammatory effects through suppression of NF-κB signalling. Studies into the ability of AFSC CM to alter the polarisation of M1 to M2 macrophages will provide further evidence of its anti-inflammatory ability as was shown recently with adipose derived MSC CM [65] . Cellular protection may also derive from the vesicular portion of the CM as evidenced by a reduction in cellular senescence with AF-EV being equally potent as AF-CM. The regulation of NF-κB signalling homesis is important in both the determination of the inflammatory response but also many other directly and indirectly related pathways such as cellular growth, proliferation and the stress response [66, 67] . These results suggest that the AF-CM including its EV fraction may drive signalling towards a normal equilibrium like-state.
Our results show that both the CM and EV from AF cells promote muscle regeneration. However we believe that the subtle differences in the results from these two experiments offer not only mechanistic insights into how this is occurring but also the relative importance of differing factors in the process. Whole CM experiment showed an increase in the number of committed muscle cells (Pax7 + /MyoD + ), an increase in capillary density and increased number of macrophages. Capillary density but not macrophage infiltration was changed in the EV experiment compared to controls.
Furthermore in the EV experiment, the number of activated precursor muscle cells was increased.
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